MTD Group completes the acquisition of Ypsomed's Pen Needles and Blood Glucose Monitoring Systems and announces a significant investment plan for its European production sites

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

MTD-Ypsomeds-BGM

More Like This

PR Newswire associated0

Abbott Enters Global Partnership to Connect Its World-Leading Continuous Glucose Monitoring System with Medtronic's Insulin Delivery Devices

PR Newswire associated0

Medtrum Advances 300U Tubeless Patch Pump Toward German Launch

Ascensia Diabetes Care Expands CONTOUR® Portfolio with CONTOUR®COMFORT Pen Needles to Bring Greater Stability and Control to the Everyday Injection Experience

Ascensia Diabetes Care Expands CONTOUR® Portfolio with CONTOUR®COMFORT Pen Needles to Bring Greater Stability and Control to the Everyday Injection Experience

MiniMed launches Instinct sensors in Europe giving people with diabetes more sensor choice with the same proven outcomes

Diamyd Medical announces expanded financial support from Breakthrough T1D

PR Newswire associated0

Datwyler, LTS Device Technologies, and Stevanato Group Collaborate to Expand Self-Delivery Options for Large-Volume Drugs

From left: Jeffrey Chen, Vice President, BD (Becton Dickinson) Greater Asia; Yoo Young-ho, President, Celltrion Pharm; and Jason Hwang, Country General Manager, BD Korea, at the trilateral agreement signing ceremony.

Celltrion Pharm Signs Strategic Trilateral Agreement with Becton Dickinson and BD Korea to Accelerate Global PFS CMO Business

PR Newswire associated0

Cap-Free, Hidden-Needle Onestep Lancing Pen Debuts in Spain--First Step of SteriLance's European Roll-out